Lung Large Cell Neuroendocrine Carcinoma: A Population-Based Retrospective Cohort Study

Backgrounds: Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a rarely high-grade neuroendocrine carcinoma of the lung with features of both small cell and non-small cell lung cancer. In this study, we aim to construct a prognostic nomogram that integrates the clinical features and treatment...

Full description

Bibliographic Details
Main Authors: Xiaoli Mu, Dan Pu, Yajuan Zhu, Yixin Zhou, Qiang Wu, Qing Liu, Liyuan Yin, Yan Li
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/12/12/4126
_version_ 1797594041336987648
author Xiaoli Mu
Dan Pu
Yajuan Zhu
Yixin Zhou
Qiang Wu
Qing Liu
Liyuan Yin
Yan Li
author_facet Xiaoli Mu
Dan Pu
Yajuan Zhu
Yixin Zhou
Qiang Wu
Qing Liu
Liyuan Yin
Yan Li
author_sort Xiaoli Mu
collection DOAJ
description Backgrounds: Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a rarely high-grade neuroendocrine carcinoma of the lung with features of both small cell and non-small cell lung cancer. In this study, we aim to construct a prognostic nomogram that integrates the clinical features and treatment options to predict disease-specific survival (DSS). Methods: A total of 713 patients diagnosed with LCNEC were from the US National Cancer Institute’s Surveillance Epidemiology and End Results (SEER) registry between 2010–2016. Cox proportional hazards analysis was conducted to choose the significant predictors of DSS. External validation was performed using 77 patients with LCNEC in the West China Hospital Sichuan University between 2010–2018. The predictive accuracy and discriminative capability were estimated by the concordance index (C-index), calibration curve, and receiver operating characteristic (ROC) curve. The clinical applicability of the nomogram was verified through the decision curve analysis (DCA). Additionally, we conducted a subgroup analysis of data available in the external cohort that may impact prognosis but was not recorded in the SEER database. Results: Six independent risk factors for DSS were identified and integrated into the nomogram. The nomogram achieved good C- indexes of 0.803 and 0.767 in the training and validation group, respectively. Moreover, the calibration curves for the probability of survival showed good agreement between prediction by nomogram and actual observation in 1-, 3- and 5-year DSS. The ROC curves demonstrated the prediction accuracy of the established nomogram (all Area Under Curve (AUC) > 0.8). DCA exhibited the favorable clinical applicability of the nomogram in the prediction of LCNEC survival. A risk classification system was built which could perfectly classify LCNEC patients into high-, medium- and low-risk groups (<i>p</i> < 0.001). The survival analysis conducted on the West China Hospital cohort indicated that whole brain radiation therapy (WBRT), prophylactic cranial irradiation (PCI), surgical procedures, tumor grade, Ki-67, and PD-L1 expression were not significantly associated with DSS. Conclusion: This study has effectively developed a prognostic nomogram and a corresponding risk stratification system, which demonstrate promising potential for predicting the DSS of patients with LCNEC.
first_indexed 2024-03-11T02:18:01Z
format Article
id doaj.art-0e571c2fba64467aa2d8cdd8c6be41e6
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-11T02:18:01Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-0e571c2fba64467aa2d8cdd8c6be41e62023-11-18T11:01:20ZengMDPI AGJournal of Clinical Medicine2077-03832023-06-011212412610.3390/jcm12124126Lung Large Cell Neuroendocrine Carcinoma: A Population-Based Retrospective Cohort StudyXiaoli Mu0Dan Pu1Yajuan Zhu2Yixin Zhou3Qiang Wu4Qing Liu5Liyuan Yin6Yan Li7The Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, ChinaLung Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, ChinaThe Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, ChinaThe Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, ChinaLung Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, ChinaDepartment of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, ChinaLung Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, ChinaLung Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, ChinaBackgrounds: Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a rarely high-grade neuroendocrine carcinoma of the lung with features of both small cell and non-small cell lung cancer. In this study, we aim to construct a prognostic nomogram that integrates the clinical features and treatment options to predict disease-specific survival (DSS). Methods: A total of 713 patients diagnosed with LCNEC were from the US National Cancer Institute’s Surveillance Epidemiology and End Results (SEER) registry between 2010–2016. Cox proportional hazards analysis was conducted to choose the significant predictors of DSS. External validation was performed using 77 patients with LCNEC in the West China Hospital Sichuan University between 2010–2018. The predictive accuracy and discriminative capability were estimated by the concordance index (C-index), calibration curve, and receiver operating characteristic (ROC) curve. The clinical applicability of the nomogram was verified through the decision curve analysis (DCA). Additionally, we conducted a subgroup analysis of data available in the external cohort that may impact prognosis but was not recorded in the SEER database. Results: Six independent risk factors for DSS were identified and integrated into the nomogram. The nomogram achieved good C- indexes of 0.803 and 0.767 in the training and validation group, respectively. Moreover, the calibration curves for the probability of survival showed good agreement between prediction by nomogram and actual observation in 1-, 3- and 5-year DSS. The ROC curves demonstrated the prediction accuracy of the established nomogram (all Area Under Curve (AUC) > 0.8). DCA exhibited the favorable clinical applicability of the nomogram in the prediction of LCNEC survival. A risk classification system was built which could perfectly classify LCNEC patients into high-, medium- and low-risk groups (<i>p</i> < 0.001). The survival analysis conducted on the West China Hospital cohort indicated that whole brain radiation therapy (WBRT), prophylactic cranial irradiation (PCI), surgical procedures, tumor grade, Ki-67, and PD-L1 expression were not significantly associated with DSS. Conclusion: This study has effectively developed a prognostic nomogram and a corresponding risk stratification system, which demonstrate promising potential for predicting the DSS of patients with LCNEC.https://www.mdpi.com/2077-0383/12/12/4126pulmonary large cell neuroendocrine carcinomadisease-specific survivalprophylactic cranial irradiationnomogram
spellingShingle Xiaoli Mu
Dan Pu
Yajuan Zhu
Yixin Zhou
Qiang Wu
Qing Liu
Liyuan Yin
Yan Li
Lung Large Cell Neuroendocrine Carcinoma: A Population-Based Retrospective Cohort Study
Journal of Clinical Medicine
pulmonary large cell neuroendocrine carcinoma
disease-specific survival
prophylactic cranial irradiation
nomogram
title Lung Large Cell Neuroendocrine Carcinoma: A Population-Based Retrospective Cohort Study
title_full Lung Large Cell Neuroendocrine Carcinoma: A Population-Based Retrospective Cohort Study
title_fullStr Lung Large Cell Neuroendocrine Carcinoma: A Population-Based Retrospective Cohort Study
title_full_unstemmed Lung Large Cell Neuroendocrine Carcinoma: A Population-Based Retrospective Cohort Study
title_short Lung Large Cell Neuroendocrine Carcinoma: A Population-Based Retrospective Cohort Study
title_sort lung large cell neuroendocrine carcinoma a population based retrospective cohort study
topic pulmonary large cell neuroendocrine carcinoma
disease-specific survival
prophylactic cranial irradiation
nomogram
url https://www.mdpi.com/2077-0383/12/12/4126
work_keys_str_mv AT xiaolimu lunglargecellneuroendocrinecarcinomaapopulationbasedretrospectivecohortstudy
AT danpu lunglargecellneuroendocrinecarcinomaapopulationbasedretrospectivecohortstudy
AT yajuanzhu lunglargecellneuroendocrinecarcinomaapopulationbasedretrospectivecohortstudy
AT yixinzhou lunglargecellneuroendocrinecarcinomaapopulationbasedretrospectivecohortstudy
AT qiangwu lunglargecellneuroendocrinecarcinomaapopulationbasedretrospectivecohortstudy
AT qingliu lunglargecellneuroendocrinecarcinomaapopulationbasedretrospectivecohortstudy
AT liyuanyin lunglargecellneuroendocrinecarcinomaapopulationbasedretrospectivecohortstudy
AT yanli lunglargecellneuroendocrinecarcinomaapopulationbasedretrospectivecohortstudy